Upcoming
June 3–6, 2026 – Glasgow, Scotland
63rd European Renal Association (ERA) Congress 2026
The Spring Clinical Meetings (SCM) is the premiere educational event presented by the National Kidney Foundation (NKF) for interprofessional kidney health teams.
Travere at NKF Spring Clinical Meetings 2026
Travere is proud to participate in the NKF Spring Clinical Meetings, contribute to scientific discussions and share insights on kidney disease.
Program
Antiproteinuric Effect of Sparsentan (SPAR) After Maximized Irbesartan (IRB) in Patients (Pts) With Focal Segmental Glomerulosclerosis (FSGS) in the DUPLEX Open-Label Extension (OLE)
Authors: Gaia Coppock, Gianna Mastroianni Kirsztajn, Jula Inrig, Kristie Kusibab, Priscila Preciado, Hernán Trimarchi
Meet a Travere MSL
Connect with a Travere Medical Science Liaison (MSL) to ask questions, receive support on Travere products, and engage in peer-to-peer discussions on disease states, clinical data, and the treatment landscape.
Schedule a meetingIn DUPLEX, Patients (Pts) With Focal Segmental Glomerulosclerosis (FSGS) Reached Low Proteinuria More Often With Sparsentan (SPAR) vs Irbesartan (IRB) Regardless of Baseline Proteinuria
Authors: Jai Radhakrishnan, German Hernandez, Jula Inrig, Radko Komers, Kristie Kusibab, Kenneth Lieberman
Proteinuria Reductions With Sparsentan (SPAR) Combined With Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2is) in Adults With IgA Nephropathy (IgAN): A Single Site Case Series
Authors: Ankit Mehta, Gustavo Borda Sanchez, Alexandra Willcockson, Agnes Block
Use of Implementation Science to Optimize Management of Rare Kidney Disease
Authors: Luis E. Vélez, Chris Gisler, Keith Latham, Michael Trabold, Kartik Kalra
